The multiple propensity score for analysis of dose-response relationships in drug safety studies

Pharmacoepidemiology and Drug Safety

Volumn 10, Issue 2, 2001, Pages 105-111

  Wang, Jixian ^a   Donnan, Peter T ^a   Steinke, Douglas ^a   MacDonald, Thomas M ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Bias adjustment; Dose response; Drug safety; Propensity score

Indexed keywords

ACETYLSALICYLIC ACID; DICLOFENAC; HISTAMINE H2 RECEPTOR ANTAGONIST; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

ADULT; ADVERSE DRUG REACTION; AGE; AGED; ARTICLE; CLINICAL OBSERVATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA BASE; DIGESTIVE SYSTEM PERFORATION; DOSE RESPONSE; DRUG INDICATION; DRUG SAFETY; ENDOSCOPY; FEMALE; GASTROINTESTINAL HEMORRHAGE; GENDER; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIAS (EPIDEMIOLOGY); CONFOUNDING FACTORS (EPIDEMIOLOGY); DICLOFENAC; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PHARMACOEPIDEMIOLOGY; RISK FACTORS; SCOTLAND;

EID: 0034955507     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.572     Document Type: Article

References (13)

1. The central role of the propensity score in observational studies for causal effects
2. The Tayside Medicines Monitoring Unit (MEMO)
3. Confounding by indication: An example of variation in the use of epidemiologic terminology
4. Reducing bias in observational studies using subclassification on the propensity score
5. The use of propensity score in pharmacoepidemiologic research Pharmacoepidemiol
6. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group
7. The role of the propensity score in estimating dose-response functions
8. Topical-non-steroidal anti-inflammatory drugs and hospitalisation for upper gastrointestinal bleeding and perforation: A record-linkage case-control study
9. Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: Cohort study
10. Regression models for ordinal data
11. Estimating exposure effects by modelling the expectation of exposure conditional on confounders